113 related articles for article (PubMed ID: 28485840)
1. Genetic landscape of clear cell endometrial cancer and the era of precision medicine.
Huang GS; Santin AD
Cancer; 2017 Sep; 123(17):3216-3218. PubMed ID: 28485840
[No Abstract] [Full Text] [Related]
2. The genetic landscape of endometrial clear cell carcinomas.
DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
[TBL] [Abstract][Full Text] [Related]
5. Targeted mutation analysis of endometrial clear cell carcinoma.
Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of endometrial cancer: entering an era of precision medicine.
Goulder A; Gaillard SL
J Gynecol Oncol; 2022 May; 33(3):e47. PubMed ID: 35443293
[No Abstract] [Full Text] [Related]
7. Appearance of primary endometrial and ovarian clear cell adenocarcinoma 17 months postpartum. A case report.
Ohwada M; Suzuki M; Ohno T; Saito K; Sato I
Acta Cytol; 1998; 42(3):765-8. PubMed ID: 9622703
[TBL] [Abstract][Full Text] [Related]
8. Endometrial clear cell adenocarcinoma diagnosed by endometrial cytological examination: two cases report.
Kinoshita Y; Takasu K; Adachi Y; Yuri T; Ikuta A; Shikata N
Diagn Cytopathol; 2011 Mar; 39(3):200-3. PubMed ID: 21319323
[TBL] [Abstract][Full Text] [Related]
9. Clear cell adenocarcinoma arising in endometrial adenofibroma.
Mikami S; Kikunaga H; Kameyama K; Mukai M
Pathol Int; 2011 Mar; 61(3):167-70. PubMed ID: 21355961
[No Abstract] [Full Text] [Related]
10. Precision medicine in endometrial cancer.
McAlpine JN; Gilks CB
Gynecol Oncol; 2019 Sep; 154(3):451-453. PubMed ID: 31472758
[No Abstract] [Full Text] [Related]
11. Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
Chang YS; Huang HD; Yeh KT; Chang JG
Int J Oncol; 2017 May; 50(5):1778-1784. PubMed ID: 28339086
[TBL] [Abstract][Full Text] [Related]
12. Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review.
Olawaiye AB; Boruta DM
Gynecol Oncol; 2009 May; 113(2):277-83. PubMed ID: 19251307
[TBL] [Abstract][Full Text] [Related]
13. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
Aquino-Parsons C; Lim P; Wong F; Mildenberger M
Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
[TBL] [Abstract][Full Text] [Related]
14. [Management for serous adenocarcinoma and clear cell adenocarcinoma of the endometrium].
Saito F; Tashiro H; Katabuchi H
Nihon Rinsho; 2012 Jun; 70 Suppl 4():438-41. PubMed ID: 23156286
[No Abstract] [Full Text] [Related]
15. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
16. Coincidental endometrial and clear cell renal carcinoma. Two case reports and literature review.
La Fianza A; Preda L; Di Maggio EM; Schifino MR; Tateo S
Radiol Med; 1998 May; 95(5):526-8. PubMed ID: 9687936
[No Abstract] [Full Text] [Related]
17. Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report.
Lee SE; Park HY; Shim SH; Kim WY
Pathol Int; 2017 Sep; 67(9):472-476. PubMed ID: 28667682
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
19. Slow and steady wins the race: precision medicine for low risk endometrial cancer.
Kurnit KC; Westin SN
Int J Gynecol Cancer; 2020 Jun; 30(6):724-725. PubMed ID: 32376741
[No Abstract] [Full Text] [Related]
20. PIK3CA mutations in ovarian cancer.
Campbell IG; Russell SE; Phillips WA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7042; author reply 7042-3. PubMed ID: 16203798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
